News
  • Autophagy inhibition enabled efficient photothermal therapy at a mild temperature
    Autophagy inhibition enabled efficient photothermal therapy at a mild temperature January 29,2024.
    Biomaterials. 2017 Oct:141:116-124.  doi: 10.1016/j.biomaterials.2017.06.030.  Epub 2017 Jun 27. Autophagy inhibition enabled efficient photothermal therapy at a mild temperature Zhengjie Zhou 1, Yang Yan 1, Kewen Hu 1, Yuan Zou 2, Yiwen Li 2, Rui Ma 1, Qiang Zhang 3, Yiyun Cheng 4 Abstract The heterogeneously-distributed hyperthermia in nanomaterial-mediated photothermal therapy commonly results in incomplete tumor eradication and serious damage of health tissue.  Here, we found autophagy was activated in cancer cells underwent photothermal therapy and the inhibition of autophagy significantly enhanced the efficacy of photothermal killing of cancer cells.  A formulation of chloroquine-loaded polydopamine nanoparticles was developed for sensitized photothermal cancer therapy, and the in vitro and in vivo study demonstrated that inhibition of autophagy remarkably augmented the efficacy of photothermal therapy, leading to efficient tumor suppression at a mild temperature.  The regulation of autophagy provides a new route to increase the efficacy of photothermal cancer therapy. Keywords: Autophagy;  Chloroquine;  Photothermal therapy;  Polydopamine nanoparticles;  Sensitization. Related products Abbreviation: mPEG-SH Name: Methoxypoly(ethylene glycol) thiol Abbreviation: H2N-PEG-SH Name: α-Amino-ω-mercapto poly(ethylene glycol) For more product information, please contact us at: US Tel: 1-844-782-5734 US Tel: 1-844-QUAL-PEG CHN Tel: 400-918-9898 Email: sales@sinopeg.com
    View More
  • Supramolecular hybrid hydrogel based on host-guest interaction and its application in drug delivery
    Supramolecular hybrid hydrogel based on host-guest interaction and its application in drug delivery January 24,2024.
    ACS Appl Mater Interfaces. 2014 Nov 26;6(22):19544-51.  doi: 10.1021/am505649q.  Epub 2014 Nov 14. Supramolecular hybrid hydrogel based on host-guest interaction and its application in drug delivery Jing Yu 1, Wei Ha, Jian-nan Sun, Yan-ping Shi Abstract In this work, we developed a simple, novel method for constructing gold nanocomposite supramolecular hybrid hydrogels for drug delivery, in which gold nanocrystals were utilized as building blocks.  First, methoxypoly(ethylene glycol) thiol (mPEG-SH, molecular weight (MW)=5 K) capped gold nanocrystals (nanospheres and nanorods) were prepared via a facile one-step ligand-exchange procedure.  Then, the homogeneous supramolecular hybrid hydrogels were formed, after adding α-cyclodextrin (α-CD) into PEG-modified gold nanocrystal solutions, due to the host-guest inclusion.  Both gold nanoparticles and inclusion complexes formed between α-CD and PEG chain provided the supra-cross-links, which are beneficial to the gelation formation.  The resulting hybrid hydrogels were fully characterized by a combination of techniques including X-ray diffraction, rheology studies, and scanning electron microscopy.  Meanwhile, the hybrid hydrogel systems demonstrated unique reversible gel-sol transition properties at a certain temperature caused by the temperature-responsive reversible supramolecular assembly.  The drug delivery applications of such hybrid hydrogels were further investigated in which doxorubicin was selected as a model drug for in vitro release, cytotoxicity, and intracellular release studies.  We believe that the development of such hybrid hydrogels will provide new and therapeutically useful means for medical applications. Keywords: drug delivery;  gold nanoparticles;  host−guest inclusion;  supramolecular hybrid hydrogel. Related products Abbreviation: mPEG-SH Name: Methoxypoly(ethylene glycol) thiol For more product information, please contact us at: US Tel: 1-844-782-5734 US Tel: 1-844-QUAL-PEG CHN Tel: 400-918-9898 Email: sales@sinopeg.com
    View More
  • Excipients for LNP Delivery Systems
    Excipients for LNP Delivery Systems January 22,2024.
    Lipid nanoparticle (LNP) delivery systems are widely used in the fields of gene therapy and vaccines.However, to achieve effective gene delivery and vaccine delivery, not only suitable carriers and nucleic acids or antigens need to be selected, but also excipients for LNP delivery systems are needed.These excipients play a key role in stability, transparency, protective effect, and charge capacity. Firstly, stability is an important characteristic of excipients for LNP delivery systems.Excipients interact with lipid components, increasing the stability of LNP.For example, polyethylene glycol (PEG) is one of the commonly used excipients, which can form a stable layer of polymer by covering the surface of LNP.This polymer layer helps to reduce protein and cell adsorption and provides additional stability, thereby prolonging the circulation life of LNP. Secondly, transparency is an important factor to be considered when designing LNP delivery systems.Transparency can affect the preparation of LNP and the visualization of the internal structure.Therefore, excipients are usually selected for their characteristics of lower absorption and scattering of light to obtain clear imaging and accurate structural analysis. In addition, excipients for LNP delivery systems can also provide protection, protecting nucleic acids or antigens from degradation. For example, cholesterol is a common excipient that can be inserted into LNP to form a barrier that protects the nucleic acid or antigen.This protective layer can prevent the nucleic acid or antigen from being attacked by enzymes and help improve delivery efficiency and immune activation. In addition, charge is also an important characteristic of excipients.Charge can affect the interaction between LNP and target cells and delivery efficiency.For example, some excipients can regulate the charge state on the surface of LNP to improve its adsorption and cell uptake, thus improving delivery effect. In summary, excipients in LNP delivery systems play an important role in gene therapy and vaccine research.By selecting appropriate excipients, the stability, transparency, protective effect and charge of LNP can be optimized to achieve efficient gene delivery and vaccine delivery.Researchers will continue to develop new excipients to further improve the performance of LNP delivery systems and promote the development of gene therapy and vaccine research. Lipids that has been registered with DMF: DLin-MC3-DMA* SM-102 (HUO)* ALC-0315 (DHA)* DHA-1 (ALC-0315 analogue) mPEG-DMG-2K ALC-0159 (mPEG-DTA)* mPEG-DTA-1-2K (ALC-0159 analogue) DSPC DOPE DOTAP-Cl Cholesterol (Plant) Click here for more lipid products * This product is protected by third-party patents. We provide patent-compliant technical consultation and services, not the product itself.
    View More
  • Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy
    Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy January 22,2024.
    Biomaterials. 2014 Aug;35(25):7058-67.    doi: 10.1016/j.biomaterials.2014.04.105.    Epub 2014 May 20. Stability enhanced polyelectrolyte-coated gold nanorod-photosensitizer complexes for high/low power density photodynamic therapy Zhenzhi Shi 1, Wenzhi Ren 1, An Gong 1, Xinmei Zhao 1, Yuehong Zou 1, Eric Michael Bratsolias Brown 2, Xiaoyuan Chen 3, Aiguo Wu 4 Abstract Photodynamic therapy (PDT) is a promising treatment modality for cancer and other malignant diseases, however safety and efficacy improvements are required before it reaches its full potential and wider clinical use.    Herein, we investigated a highly efficient and safe photodynamic therapy procedure by developing a high/low power density photodynamic therapy mode (high/low PDT mode) using methoxypoly(ethylene glycol) thiol (mPEG-SH) modified gold nanorod (GNR)-AlPcS4 photosensitizer complexes.    mPEG-SH conjugated to the surface of simple polyelectrolyte-coated GNRs was verified using Fourier transform infrared spectroscopy;    this improved stability, reduced cytotoxicity, and increased the encapsulation and loading efficiency of the nanoparticle dispersions.    The GNR-photosensitizer complexes were exposed to the high/low PDT mode (high light dose = 80 mW/cm(2) for 0.5 min;    low light dose = 25 mW/cm(2) for 1.5 min), and a high PDT efficacy leads to approximately 90% tumor cell killing.    Due to synergistic plasmonic photothermal properties of the complexes, the high/low PDT mode demonstrated improved efficacy over using single wavelength continuous laser irradiation.    Additionally, no significant loss in viability was observed in cells exposed to free AlPcS4 photosensitizer under the same irradiation conditions.    Consequently, free AlPcS4 released from GNRs prior to cellular entry did not contribute to cytotoxicity of normal cells or impose limitations on the use of the high power density laser.    This high/low PDT mode may effectively lead to a safer and more efficient photodynamic therapy for superficial tumors. Keywords: AlPcS4 photosensitizer;    Gold nanorods;    High/low power density;    Near-infrared;    Photodynamic therapy (PDT);    Synergistic therapy. Related products Abbreviation: mPEG-SH Name: Methoxypoly(ethylene glycol) thiol For more product information, please contact us at: US Tel: 1-844-782-5734 US Tel: 1-844-QUAL-PEG CHN Tel: 400-918-9898 Email: sales@sinopeg.com
    View More
  • Visit SINOPEG at the 3rd Annual LNP Formulation & Process Development Summit
    Visit SINOPEG at the 3rd Annual LNP Formulation & Process Development Summit January 19,2024.
    We are delighted to announce that SINOPEG will be participating in the LNP Formulation & Process Development Summit 2024 Agreement, scheduled to take place on April 29, 2024, in Boston, USA. This prestigious exhibition offers a unique platform for industry professionals to gather and exchange valuable insights on the latest advancements in LNP formulation and process development. We extend a warm welcome to everyone interested in this field to join us at this exciting event. Powered by latest developments with LNP CRISPR gene editing in the lungs, Bayer and Acuitas uniting to strengthen their Gene Therapy portfolio, new biotech ReNAgade Therapeutics launching with $300m Series A financing, lipid nanoparticles continue to dominate biopharma pipelines in 2024 and beyond as the most successful non-viral delivery vehicle to date. Moving into novel applications from gene therapy and cell therapy, and new disease indications from oncology to rare disease, LNP are equipping scientists with the ability to deliver transformative medicines to patients. With industry at a critical inflection point as a need to demonstrate clinical advancements for confidence to advance pipelines in 2024, the 3rd LNP Formulation & Process Development Summit will unite again in April with 4 tracks of carefully curated content as the industry’s one-stop-shop to evaluate and optimize LNPs end-to-end development for your given target of interest. *60+ expert speakers pioneering the next generation of LNP drug products *Content from early-stage discovery through the commercialized manufacture at large scale *A plethora of payloads, disease indications and route of administration *8 in-depth workshops, LNP 101 focus day, IP Patenting & Commercial Partnerships focus day, and 10+ hours of dedicated networking *Countless new topics, new speakers and new companies Date: April 29, 2024 Location:Boston, USA For more information and registration details, please visit the official website of the LNP Formulation & Process Development Summit 2024 Agreement. The LNP Formulation & Process Development Summit 2024 Agreement in Boston is an event not to be missed for professionals in the field of LNP formulation and process development.  We look forward to welcoming you to this exciting exhibition, where we can collectively contribute to the advancement of this rapidly evolving field. See you there!
    View More
  • Safety profile of two-dimensional Pd nanosheets for photothermal therapy and photoacoustic imaging
    Safety profile of two-dimensional Pd nanosheets for photothermal therapy and photoacoustic imaging January 18,2024.
    Research Article | Issue | Published: 06 December 2016 Safety profile of two-dimensional Pd nanosheets for photothermal therapy and photoacoustic imaging Mei Chen1,§, Shuzhen Chen2,3,§, Chengyong He2,§, Shiguang Mo1, Xiaoyong Wang2, Gang Liu2, Nanfeng Zheng1 Abstract Two-dimensional (2D) nanosheets have emerged as an important class of nanomaterial with great potential in the field of biomedicines, particularly in cancer theranostics.   However, owing to the lack of effective methods that synthesize uniform 2D nanomaterials with controlled size, systematic evaluation of size-dependent bio-behaviors of 2D nanomaterials is rarely reported.   To the best of our knowledge, we are the first to report a systematic evaluation of the influence of size of 2D nanomaterials on their bio-behaviors.   2D Pd nanosheets with diameters ranging from 5 to 80 nm were synthesized and tested in cell and animal models to assess their size-dependent bioapplication, biodistribution, elimination, toxicity, and genomic gene expression profiles.   Our results showed size significantly influences the biological behaviors of Pd nanosheets, including their photothermal and photoacoustic effects, pharmacokinetics, and toxicity.   Compared to larger-sized Pd nanosheets, smaller-sized Pd nanosheets exhibited more advanced photoacoustic imaging and photothermal effects upon ultralow laser irradiation.   Moreover, in vivo results indicated that 5-nm Pd nanosheets escape from the reticuloendothelial system with a longer blood half-life and can be cleared by renal excretion, while Pd nanosheets with larger sizes mainly accumulate in the liver and spleen.   The 30-nm Pd nanosheets exhibited the highest tumor accumulation.   Although Pd nanosheets did not cause any appreciable toxicity at the cellular level, we observed slight lipid accumulation in the liver and inflammation in the spleen.   Genomic gene expression analysis showed that 80-nm Pd nanosheets interacted with more cellular components and affected more biological processes in the liver, as compared to 5-nm Pd nanosheets.   We believe this work will provide valuable information and insights into the clinical application of 2D Pd nanosheets as nanomedicines. Related products Abbreviation: mPEG-SH Name: Methoxypoly(ethylene glycol) thiol For more product information, please contact us at: US Tel: 1-844-782-5734 US Tel: 1-844-QUAL-PEG CHN Tel: 400-918-9898 Email: sales@sinopeg.com
    View More
  • Rattle-type Au@Cu2-xS hollow mesoporous nanocrystals with enhanced photothermal efficiency for intracellular oncogenic microRNA detection and chemo-photothermal therapy
    Rattle-type Au@Cu2-xS hollow mesoporous nanocrystals with enhanced photothermal efficiency for intracellular oncogenic microRNA detection and chemo-photothermal therapy January 15,2024.
    Biomaterials. 2018 Mar:158:23-33.   doi: 10.1016/j.biomaterials.2017.12.009.   Epub 2017 Dec 13. Rattle-type Au@Cu2-xS hollow mesoporous nanocrystals with enhanced photothermal efficiency for intracellular oncogenic microRNA detection and chemo-photothermal therapy Yu Cao 1, Shuzhou Li 2, Chao Chen 2, Dongdong Wang 1, Tingting Wu 1, Haifeng Dong 3, Xueji Zhang 4 Abstract The coupling of the localized surface plasma resonance (LSPR) between noble metals of Au, Ag and Cu and semiconductors of Cu2-xE (E = S, Se, Te) opens new regime to design photothermal (PT) agents with enhanced PT conversion efficiency.   However, it is rarely explored on fabricating of engineered dual plasmonic hybrid nanosystem for combinatory therapeutic-diagnostic applications.   Herein, rattle-type Au@Cu2-xS hollow mesoporous nanoparitcles with advanced PT conversion efficiency are designed for cellular vehicles and chemo-photothermal synergistic therapy platform.   The LSPR coupling between the Au core and Cu2-xS shell are investigated experimentally and theoretically to generate a PT conversion efficiency high to 35.2% and enhanced by 11.3% than that of Cu2-xS.   By conjugating microRNA (miRNA) gene probe on the surface, it can realize the intracellular oncogenic miRNA detection.   After loading of anticancer drug doxorubicin into the cavity of the Au@Cu2-xS, the antitumor therapy efficacy is greatly enhanced in vitro and in vivo due to the NIR photoactivation chemo- and photothermal synergistic therapy.   The rattle-type metal-semiconductor hollow mesoporous nanostructure with efficient LSPR coupling and high cargo loading capability will be beneficial to future design of LSPR-based photothermal agents for a broad range of biomedical application. Keywords: Chemo-photothermal therapy;   Localized surface plasma resonance coupling;   MicroRNA detection;   Rattle-type Au@Cu(2−x)S;   Theranostic platform. Related products Abbreviation: mPEG-SH Name: Methoxypoly(ethylene glycol) thiol For more product information, please contact us at: US Tel: 1-844-782-5734 US Tel: 1-844-QUAL-PEG CHN Tel: 400-918-9898 Email: sales@sinopeg.com
    View More
  • Pd nanosheets with their surface coordinated by radioactive iodide as a high-performance theranostic nanoagent for orthotopic hepatocellular carcinoma imaging and cancer therapy
    Pd nanosheets with their surface coordinated by radioactive iodide as a high-performance theranostic nanoagent for orthotopic hepatocellular carcinoma imaging and cancer therapy January 12,2024.
    Chem Sci. 2018 Apr 12;9(18):4268-4274.  doi: 10.1039/c8sc00104a.  eCollection 2018 May 14. Pd nanosheets with their surface coordinated by radioactive iodide as a high-performance theranostic nanoagent for orthotopic hepatocellular carcinoma imaging and cancer therapy Mei Chen 1 2, Zhide Guo 3, Qinghua Chen 4, Jingping Wei 1, Jingchao Li 1, Changrong Shi 3, Duo Xu 3, Dawang Zhou 4, Xianzhong Zhang 3, Nanfeng Zheng 1 Abstract Radiolabeled nanoparticles (NPs), taking advantage of nanotechnology and nuclear medicine, have shown attractive potential for cancer diagnosis and therapy.  However, the high background signal in the liver and long-term toxic effects of radioisotopes caused by the nonselective accumulation of radiolabeled nanoparticles in organs have become the major challenges.  Here, we report a pH-sensitive multifunctional theranostic platform with radiolabeled Pd nanosheets through a simple mixture of ultra-small Pd nanosheets and radioisotopes utilizing the strong adsorption of 131I and 125I on their surfaces (denoted as 131I-Pd-PEG or 125I-Pd-PEG).  Systematic studies reveal that the labeling efficiency is higher than 98% and the adsorption of radioiodine is more stable in an acidic environment.  In vivo studies further validate the pH-dependent behavior of this platform and the enhanced retention of radioisotopes in tumors due to the acidic microenvironment.  Single photon emission computed tomography (SPECT) images with zero background were successfully achieved in a subcutaneous 4T1 tumor model, an orthotopic LM3 tumor model, and even in a Mst1/2 double-knockout hepatoma model.  Moreover, the application of radiolabeled Pd nanosheets for photoacoustic (PA) imaging, and combined photothermal and radiotherapy was also explored.  Therefore, this study provides a simple and efficient strategy to solve the critical high background issue of radiolabeled nanoparticles and shows enormous potential for clinical applications. Related products Abbreviation: mPEG-SH Name: Methoxypoly(ethylene glycol) thiol For more product information, please contact us at: US Tel: 1-844-782-5734 US Tel: 1-844-QUAL-PEG CHN Tel: 400-918-9898 Email: sales@sinopeg.com
    View More
first page 11 12 13 14 15 16 17 18 19 20 last page

A total of 30 pages

Copyright © XIAMEN SINOPEG BIOTECH CO., LTD. All Rights Reserved.

Home

Products

News

contact